GM-CSF autoantibodies in pulmonary alveolar proteinosis

被引:1
|
作者
Busch, Thilo [1 ]
Bercker, Sven [1 ]
Kaisers, Udo [1 ]
机构
[1] Univ Leipzig, D-04103 Leipzig, Germany
来源
NEW ENGLAND JOURNAL OF MEDICINE | 2007年 / 356卷 / 19期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:2001 / 2002
页数:2
相关论文
共 50 条
  • [21] Aerosolized GM-CSF Therapy of Pulmonary Alveolar Proteinosis (PAP).
    Tazawa, R.
    Inoue, Y.
    Takada, T.
    Arai, T.
    Nasuhara, Y.
    Hizawa, N.
    Kasahara, Y.
    Tatsumi, K.
    Hojo, M.
    Yokoba, M.
    Tanaka, N.
    Yamaguchi, E.
    Eda, R.
    Tsuchihashi, Y.
    Oishi, K.
    Terada, M.
    Kaneko, C.
    Nukiwa, T.
    Krischer, J. P.
    Trapnell, B. C.
    Nakata, K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [22] Pulmonary alveolar proteinosis: a complete response to GM-CSF therapy
    Barraclough, RM
    Gillies, AJ
    THORAX, 2001, 56 (08) : 664 - 665
  • [23] Aerosolized GM-CSF ameliorates pulmonary alveolar proteinosis in GM-CSF-deficient mice
    Reed, JA
    Ikegami, M
    Cianciolo, ER
    Lu, W
    Cho, PS
    Hull, W
    Jobe, AH
    Whitsett, JA
    AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 1999, 276 (04) : L556 - L563
  • [24] Light chain (κ/λ) ratio of GM-CSF autoantibodies is associated with disease severity in autoimmune pulmonary alveolar proteinosis
    Nei, Takahito
    Urano, Shinya
    Itoh, Yuko
    Kitamura, Nobutaka
    Hashimoto, Atsushi
    Tanaka, Takahiro
    Motoi, Natsuki
    Kaneko, Chinatsu
    Tazawa, Ryushi
    Nakagaki, Kazuhide
    Arai, Toru
    Inoue, Yoshikazu
    Nakata, Koh
    CLINICAL IMMUNOLOGY, 2013, 149 (03) : 357 - 364
  • [25] GM-CSF Inhalation Promotes the Clearance of GM-CSF Autoantibody in the Lung of Autoimmune Pulmonary Alveolar Proteinosis.
    Nakata, K.
    Ohashi, K.
    Tazawa, R.
    Inoue, Y.
    Trapnell, B. C.
    Terada, M.
    Nakayama, H.
    Takada, T.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [26] Lentivirus GM-CSF gene therapy for autoimmune pulmonary alveolar proteinosis
    Lund-Palau, Helena
    Pilou, Aikaterini
    Atsumi, Naoko
    Pringle, Ian
    Ashworth, R. C.
    Meng, C.
    Chan, Mario
    Gill, Deborah
    Hyde, Stephen
    Morgan, Cliff
    Alton, E. W. F. W.
    Griesenbach, Uta
    HUMAN GENE THERAPY, 2018, 29 (07) : A2 - A2
  • [27] Anti-GM-CSF titer predicts response to GM-CSF therapy in pulmonary alveolar proteinosis
    Bonfield, TL
    Kavuru, MS
    Thomassen, MJ
    CLINICAL IMMUNOLOGY, 2002, 105 (03) : 342 - 350
  • [28] Occupational inhalational exposure and serum GM-CSF autoantibody in pulmonary alveolar proteinosis
    Xiao, Yong-Long
    Xu, Kai-Feng
    Li, Yan
    Li, Yan
    Li, Hui
    Shi, Bin
    Zhou, Ke-Feng
    Zhou, Zheng-Yang
    Cai, Hou-Rong
    OCCUPATIONAL AND ENVIRONMENTAL MEDICINE, 2015, 72 (07) : 504 - 512
  • [29] A Mechanism For Acceleration Of Gm-Csf Autoantibody Production In Autoimmune Pulmonary Alveolar ProteINOSis
    Nakata, K.
    Nei, T.
    Motoi, N.
    Urano, S.
    Tazawa, R.
    Nakagaki, K.
    Suzuki, M.
    Takizawa, J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [30] NOVEL GM-CSF RECEPTOR MUTATION PRESENTING WITH PULMONARY ALVEOLAR PROTEINOSIS IN CHILDHOOD
    KUMAR, K.
    MATHEW, J. L.
    SINGH, M.
    SINGHAL, K. K.
    SINGH, S.
    GANTA, A. R.
    SODH, K. S., I
    GUPTA, N.
    BAL, A.
    MENON, P.
    CHEST, 2022, 161 (06) : 264A - 264A